Japan's Chugai files to expand use of COVID-19 antibody drug
Japan's Chugai Pharmaceutical Co said on Monday it has applied to regulators to expand the use of an antibody treatment for COVID-19 to also allow for preventative care. Japanese regulators approved an antibody cocktail known as Ronapreve as a treatment for COVID-19 in July. The latest filing seeks to use the drug as both a prophylaxis for COVID-19 and as treatment of asymptomatic cases, Chugai said in a release.
Reuters - October 11, 2021View the full story here: https://www.reuters.com/world/asia-pacific/japans-chugai-files-expand-use-covid-19-antibody-drug-2021-10-11/